Evidence map›Paper›PMID 33092154›Full record

ReviewGels (Basel, Switzerland)2020

Type I Collagen-Fibrin Mixed Hydrogels: Preparation, Properties and Biomedical Applications.

Thibaud Coradin, Kun Wang, Thalie Law, Léa Trichet

Abstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Bone Regeneration: Mini-Review and Appealing Perspectives.Bioengineering (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thibaud CoradinSorbonne Université, CNRS, Laboratoire de Chimie de la Matière Condensée de Paris, 4 place Jussieu, 75005 Paris, France.
Kun WangSorbonne Université, CNRS, Laboratoire de Chimie de la Matière Condensée de Paris, 4 place Jussieu, 75005 Paris, France.
Thalie LawSorbonne Université, CNRS, Laboratoire de Chimie de la Matière Condensée de Paris, 4 place Jussieu, 75005 Paris, France.
Léa TrichetSorbonne Université, CNRS, Laboratoire de Chimie de la Matière Condensée de Paris, 4 place Jussieu, 75005 Paris, France.

Funding

Agence Nationale de la Recherche ANR-10-LBX-0067China Scolarship Council N/A
6 · The paper itself

Abstract

Type I collagen and fibrin are two essential proteins in tissue regeneration and have been widely used for the design of biomaterials. While they both form hydrogels via fibrillogenesis, they have distinct biochemical features, structural properties and biological functions which make their combination of high interest. A number of protocols to obtain such mixed gels have been described in the literature that differ in the sequence of mixing/addition of the various reagents. Experimental and modelling studies have suggested that such co-gels consist of an interpenetrated structure where the two proteins networks have local interactions only. Evidences have been accumulated that immobilized cells respond not only to the overall structure of the co-gels but can also exhibit responses specific to each of the proteins. Among the many biomedical applications of such type I collagen-fibrin mixed gels, those requiring the co-culture of two cell types with distinct affinity for these proteins, such as vascularization of tissue engineering constructs, appear particularly promising.

Indexed as

fibrinhydrogelstype I collagen

Identifiers

PMID33092154
PMCPMC7709698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.